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Abstract 16 
Routine application of antimicrobials is the current treatment of choice for rainbow trout 17 
fry syndrome (RTFS) or bacterial coldwater disease (BCWD) caused by Flavobacterium 18 
psychrophilum. In this study, the antimicrobial susceptibilities of 133 F. psychrophilum 19 
isolates, 118 of which were from the UK, were evaluated by broth microdilution and disc 20 
diffusion methods following VET04-A2 and VET03-A guidelines of Clinical and 21 
Laboratory Standards Institute (CLSI), respectively. Isolates were categorised as wild 22 
type (fully susceptible, WT) or non-wild type (NWT) using normalised resistance 23 
interpretation (NRI) determined cut-off values (COWT). Broth microdilution testing 24 
showed that only 12% of UK isolates were WT to oxolinic acid (MIC COWT 0.25 mg L-25 
1) and 42% were WT for oxytetracycline (MIC COWT 0.25 mg L-1). In contrast, all the 26 
isolates tested were WT (MIC COWT 2 mg L-1) for florfenicol, the main antimicrobial 27 
for RTFS control in the UK. Disc diffusion-based COWT values were ≥51 mm for 10 µg 28 
amoxicillin, ≥44 mm for 30 µg florfenicol, ≥30 mm for 2 µg oxolinic acid and ≥51 mm 29 
for 30 µg oxytetracycline. There was a high categorical agreement between the 30 
classifications of the isolates by two testing methods for florfenicol (100%), 31 
oxytetracycline (93%), and oxolinic acid (99%). 32 
 33 
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Introduction 36 
Flavobacterium psychrophilum, a Gram-negative, filamentous, psychrotrophic bacterium, 37 
is the aetiological agent of rainbow trout fry syndrome (RTFS) and bacterial coldwater 38 
disease (BCWD), which was first described in USA in 1946 (Borg 1948). F. 39 
psychrophilum infection has been found throughout North America, Europe and 40 
elsewhere in Turkey, Australia, Peru, Japan and Korea (Barnes & Brown 2011). A 41 
commercial vaccine against RTFS/BCWD is still not available (Gómez et al. 2014). 42 
Alhtough phage therapy (Stenholm et al. 2008; Kim et al. 2010a; Castillo et al. 2012) and 43 
the use of probiotic bacteria (StrömBesto & Wiklund 2011; Korkea-aho et al. 2011; 44 
Boutin et al. 2012; Burbank et al. 2012) have been suggested to be a promising 45 
alternative to the use of antibiotics in aquaculture, further studies are needed to prove the 46 
consistent effect of these green/blue technologies on preventing the infection of F. 47 
psychrophilum. Therefore, the use of antibiotics is currently the treatment of choice for 48 
controlling RTFS/BCWD outbreaks, resulting in a concern about the development of 49 
antimicrobial resistance by F. psychrophilum (Gómez et al. 2014). In the UK, three 50 
antibiotics (florfenicol, oxytetracycline and amoxicillin) are licensed for use in 51 
aquaculture by the UK Veterinary Medicines Directorate (VMD) 52 
(http://www.vmd.defra.gov.uk/). 53 
Several studies have examined the antimicrobial susceptibility of F. psychrophilum 54 
isolated from the USA (Pacha 1968, Soule et al. 2005; Van Vliet et al. 2017), the UK 55 
(Rangdale et al. 1997; Verner-Jeffreys & Taylor 2015; Smith et al. 2016), Denmark 56 
(Lorenzen et al. 1997; Bruun et al. 2000; Dalsgaard & Madsen 2000; Schmidt et al. 57 
2000; Bruun et al. 2003; Smith et al. 2016), France (Michel et al. 2003), Japan (Izumi & 58 
Aranishi 2004), Turkey (Kum et al. 2008; Durmaz et al. 2012; Boyacioğlu & Akar 2012; 59 
Boyacioğlu et al. 2015), Canada (Hesami et al. 2010), Spain (Del Cerro et al. 2010), 60 
Norway (Nilsen et al. 2011), Chile (Henríquez-Núñez et al. 2012; Miranda et al. 2016) 61 
and Finland (Sundell et al. 2013). However, differences in the medium and growth 62 
conditions used in these studies and variations in the interpretive criteria used make 63 
comparisons difficult. In addition, some of these studies included only a small number of 64 
isolates, while others produced susceptibility data that was too diverse to allow any 65 
estimate of cut-off values to interpret their meaning. 66 
Smith et al. (2013) addressed the need for standardised and internationally 67 
recognized protocols for laboratory in vitro susceptibility testing in monitoring and 68 
surveillance programmes and the use of standardised methods to calculate 69 
epidemiological cut-off values for interpretation of the meaning of the data collected in 70 
such surveys.  71 
The aim of the present study was to evaluate the antimicrobial susceptibility of 140 72 
F. psychrophilum isolates, 125 of which were obtained within the UK, by the disc 73 
diffusion and standardised broth microdilution methods following VET03-A (CLSI 2006) 74 
and VET04-A2 (CLSI 2014a) guidelines respectively, as recommended by the Clinical 75 
and Laboratory Standards Institute (CLSI) for aquatic bacteria with an optimal growth 76 
temperature below 35oC. 77 
 78 
Materials and Methods 79 
Bacterial isolates and growth conditions 80 
A total of 140 F. psychrophilum isolates, previously described by Ngo et al. (2017) for 81 
genetic and serological diversity, were examined in this study. This collection comprised 82 
125 isolates obtained within the UK during 2005-2015 and 15 isolates from other 83 
countries (France, Denmark, Finland, Ireland, Chile and the USA) (Table 1 and 2); 123 84 
F. psychrophilum isolates were obtained from rainbow trout (Oncorhynchus mykiss), 16 85 
from Atlantic salmon (Salmo salar) and one from coho salmon (O. kisutch). F. 86 
psychrophilum type strain NCIMB 1947T (ATCC 49418T) was included for comparative 87 
purposes. For all the experiments, the F. psychrophilum isolates were grown in Modified 88 
Veggietone (MV) medium [veggitones GMO-free soya peptone (Oxoid, UK), 5 g L-1; 89 
yeast extract (Oxoid, UK), 0.5 g L-1; magnesium sulphate heptahydrate (Fisher chemicals, 90 
UK), 0.5 g L-1; anhydrous calcium chloride (BHD), 0.2 g L-1; dextrose (Oxoid, UK), 2 g 91 
L-1; agar (solid medium; Oxoid, UK), 15 g L-1; pH 7.3] at 18oC for 72 – 96 h. Broth 92 
cultures were shaken at 140 rpm. Stock cultures were maintained at -70oC in tryptone–93 
yeast extract–salts medium supplemented with glucose [FLP – tryptone (Oxoid, UK), 4.0 94 
g L-1; yeast extract, 0.4 g L-1; anhydrous calcium chloride, 0.2 g L-1; magnesium sulphate 95 
heptahydrate, 0.5 g L-1; D(+)-glucose (Sigma, UK), 0.5 g L-1; Cepeda et al. 2004] with 96 
10% glycerol and on Protect-Multi-purpose cryobeads (Technical Service Consultants 97 
Ltd, UK).  98 
The 125 isolates from 27 sites within the UK in this study had been isolated 99 
between 2005 and 2015 with the majority (110 strains, 88%) being retrieved between 100 
2011 and 2013. Among these isolates, 51 genotypes and 7 plasmid profiles were detected 101 
(Ngo et al. 2017) (Table 1). However, within this set of 125 isolates, there were five 102 
groups of two or three isolates that were recorded as having the same site, sampling time 103 
point, genetic profiles and susceptibilities. In order to avoid the over-representation, 7 104 
potential replicates were eliminated from the analysis and only 118 UK isolates were 105 
included in the analyses. The epidemiological cut-off values were calculated from the 106 
data obtained from 118 UK isolates and 15 isolates from other countries. The frequencies 107 
of NWT phenotypes circulating the UK during 2005 – 2015 were estimated from the 108 
analysis of 118 isolates.  109 
 110 
Minimum inhibitory concentration (MIC) testing 111 
The MICs for F. psychrophilum isolates were performed using Sensititre CMP1MSP 112 
plates (Trek Diagnostic Systems; ThermoScientific.com/microbiology). These test plates 113 
were 96-well, dry-form plates that contained twofold serial dilutions of the following 114 
antimicrobial agents: ampicillin (AMP) 0.03–16 mg L-1, amoxicillin (AMOX) 0.25–16 115 
mg L-1, erythromycin (ERY) 0.25–128 mg L-1, enrofloxacin (ENRO) 0.002–1 mg L-1, 116 
florfenicol (FFN) 0.03–16 mg L-1, flumequine (FLUQ) 0.008–4 mg L-1, 117 
ormetoprim/sulphadimethoxine (PRI) 0.008/0.15–4/76 mg L-1, oxolinic acid (OXO) 118 
0.004–2 mg L-1, oxytetracycline (OTC) 0.015–8 mg L-1 and 119 
trimethoprim/sulphamethoxazole (SXT) 0.015/0.3–1/19 mg L-1. 120 
The MIC assays were determined using the broth microdilution protocol 121 
recommended for F. psychrophilum in the CLSI guideline VET04-A2 (CLSI 2014a). 122 
Colony counts on inoculum suspensions were performed to ensure that the final inoculum 123 
density was close to 5.0 x 105 colony-forming units (CFU) per millilitre.  124 
 125 
Disc diffusion testing 126 
Disc diffusion susceptibility of the F. psychrophilum strains was determined by the 127 
protocol suggested in the guideline VET03-A (CLSI 2006) with modification on the agar 128 
percentage of the culture medium. It should be noted, however, that this protocol has not 129 
been formally accepted as a standard by CLSI. The test was performed on diluted 130 
Mueller-Hinton medium (Sigma-Aldrich, UK; 3 g L-1) containing 1.5% agar (Agar No. 131 
1,  LP0011, Oxoid, UK) (MHA) and 5% foetal calf serum (FCS; Gibco, Fisher 132 
chemicals, UK) and plates were incubated at 15oC for 68 – 72 h. Antimicrobial agent 133 
discs (Oxoid, Basingstoke, UK) containing 10 µg amoxicillin (AMOX10), 5 µg 134 
enrofloxacin (ENRO5), 30 µg florfenicol (FFN30), 2 µg oxolinic acid (OXO2), 30 µg 135 
oxytetracycline (OTC30) and 25 µg trimethoprim/sulphamethoxazole (SXT25) were 136 
employed.  137 
 138 
Quality control 139 
As specified in VET04-A2 (CLSI 2014a) the quality control strain Escherichia coli 140 
NCIMB 12210 (ATCC® 25922) was included in every MIC test run and was assayed on 141 
diluted CAMHB at 18oC as described above. However, no quality control ranges have 142 
been established for any disc diffusion protocol specifying these incubation conditions 143 
(CLSI 2006). Therefore, the F. psychrophilum type strain NCIMB 1947T was also 144 
included in every test run to monitor the performance of the method. 145 
 146 
Statistical analysis 147 
The antimicrobial susceptibility patterns of 133 F. psychrophilum isolates used in this 148 
study were analysed by application of protocol and species-specific epidemiological cut-149 
off values (COWT). These values allow isolates to be categorised as fully susceptible 150 
(wild type, WT) or manifesting reduced susceptibility (non-wild type, NWT). In this 151 
work, COWT values were calculated for both the MIC and disc diffusion data by the 152 
normalised resistance interpretation (NRI) method (Kronvall 2003; 2010). This NRI 153 
method was used with permission from the patent holder, Bioscand AB, TÄY, Sweden 154 
(European patent No 1383913, US patent No 7,465,559). 155 
MIC distributions were analysed using the NRI method of Kronvall (2010). A fully 156 
automatic Excel spreadsheet for performing these NRI analyses is available on-line 157 
(http://www.bioscand.se/nri/). In data sets where a small percentage (<5 %) of the WT 158 
observations were “below-scale”, these observations were treated as having the MIC 159 
value immediately below the limit of the plate quantitation. When the percentage of the 160 
WT observations “below-scale” was >5%, the data set was considered as unsuitable for 161 
NRI analysis (Smith et al. 2016). 162 
The NRI analyses for zone histograms were performed using a modification of the 163 
standardised protocol developed by Kronvall & Smith (2016). In this modification, the 164 
peak values of the zone sizes for the putative WT isolates were established using 8-point 165 
rather than 4-point rolling means.  166 
 167 
Terminology  168 
The acronyms ECV and ECOFF have been used by the CLSI and European Committee 169 
on antimicrobial susceptibility testing (EUCAST) respectively for epidemiological cut-170 
off values set from data generated in multiple laboratories. In the present study, the term 171 
COWT, as previously employed by Smith et al. (2016), was used to indicate 172 
epidemiological cut-off values that have not been set by either of these international 173 
agencies. It has been suggested that the terms resistant and sensitive should not be used to 174 
refer to the categories identified by epidemiological cut-off values (Silley 2012). 175 
Following this suggestion, when isolates are categorised by epidemiological cut-off 176 
values, the terms wild type (WT) and non-wild type (NWT) should be used for fully 177 
susceptible isolates and isolates exhibiting reduced susceptibility respectively.  178 
 179 
Results  180 
Quality control 181 
The MIC values obtained with the quality control reference strain E. coli NCIMB 12210, 182 
grown at 18oC for 72-96 h in diluted CAMHB, were within the acceptable range 183 
published by CLSI in VET03/04-S2 guideline (CLSI 2014b). All the inoculum 184 
suspensions used in MIC tests were confirmed to have the density ranging from 4.8 x 105 185 
to 5.3 x 105 CFU mL-1 by colony counts. 186 
F. psychrophilum type strain NCIMB 1947T was included in all disc diffusion tests 187 
and the inhibition zone data of this strain were 56 – 72 mm for AMOX10, 60 – 75 mm for 188 
ENRO5, 57 – 64 mm for  FFN30, 64 – 86 mm for OTC30, 45 – 56 mm for OXO2 and 16 – 189 
44 mm for  SXT25. The mean of the ranges of these zone sizes for these six agents against 190 
the F. psychrophilum type strain was 16.5 ± 7.6 mm.  191 
 192 
NRI analysis of susceptibility data  193 
The distribution of MIC values of 133 F. psychrophilum isolates for ten antimicrobial 194 
agents is shown in Table 3 and 4. MIC-based COWT values of antimicrobial agents are 195 
presented in Table 5. The distribution of disc diffusion zones of the isolates for six 196 
antimicrobials is presented in Figure 1 and the zone data-based COWT values of 197 
antimicrobial agents are shown in Table 6. 198 
 199 
Oxytetracycline  200 
MIC data for OTC showed a clear bimodal distribution (Table 3). The modal group with 201 
lower MICs was assumed to represent the WT group. NRI analysis calculated the 202 
standard deviation of the log2 normalised WT distribution as 0.68 and a COWT value of 203 
≤0.25 mg L-1 (Table 5). Applying this cut-off, fifty-six (42%) of the 133 isolates analysed 204 
were categorised as WT.  205 
The disc diffusion zone sizes for OTC30 showed considerable diversity at the high 206 
zone end (Figure 1A). However, NRI analysis of these data identified a high zone modal 207 
group with a standard deviation of 7.44 mm. If this modal group was assumed to 208 
represent zones obtained from WT isolates, a provisional COWT value of ≥51 mm could 209 
be calculated (Table 6). Applying this cut-off, sixty-five (49%) of the 133 isolates 210 
analysed were categorised as WT. 211 
The categorisation of isolates resulting from applying the cut-off of ≤0.25 mg L-1 to 212 
the MIC data agreed with the categorisation resulting from applying the disc zone cut-off 213 
of ≥51 mm to the zone data for 93% of the 133 isolates studied (Figure 2A). 214 
 215 
Amoxicillin and ampicillin  216 
For AMOX, 98 observations (100% of the lower MIC modal observations) and for AMP, 217 
24 observations (24% of the lower MIC modal observations) were recorded as “below-218 
scale” (Table 3). On this basis, neither of these data sets was considered suitable for NRI 219 
analysis. 220 
As in MIC data set for AMP there was a clear separation of the low MIC and high 221 
MIC modal groups, this data set was considered suitable for estimating COWT by visual 222 
examination. The estimated value generated by this subjective method was ≤0.125 mg L-1 223 
for AMP. A scatterplot of the paired MIC data for these two beta-lactam agents (Figure 224 
3A) suggested a high correlation between them and also demonstrated that AMOX might 225 
have the same distribution as AMP.  226 
The disc diffusion zone sizes for AMOX10 were also bimodal (Figure 1B). NRI 227 
analysis of these data calculated a standard deviation of the normalised WT distribution 228 
of 5.2 mm and a COWT value of ≥56 mm (Table 6). A scatterplot of the paired MIC 229 
values vernus inhibition zone sizes for amoxicillin suggested a high correlation between 230 
them (Figure 2B).  231 
 232 
Florfenicol  233 
MIC data for FFN showed a clear unimodal distribution (Table 3). This modal group was 234 
assumed to represent the WT isolates. NRI analysis calculated a standard deviation of the 235 
log2 normalised WT distribution of 0.68 and a COWT value of ≤2 mg L-1 (Table 5).  236 
The disc diffusion zone sizes for FFN30 were also unimodal (Figure 1C). NRI 237 
analysis of these data calculated a standard deviation of the normalised WT distribution 238 
of 5.6 mm and a COWT value of ≥45 mm (Table 6).  239 
Applying the cut-off of ≤2 mg L-1 to the MIC data and the disc zone cut-off of ≥41 240 
mm to the zone data categorised 100% of the 133 isolates studied as WT (Figure 2C). 241 
 242 
Oxolinic acid, Flumequine and Enrofloxacin 243 
The MIC values of OXO, FLUQ and ENRO were bimodally distributed (Table 3). NRI 244 
analysis calculated the standard deviation of the log2 normalised WT distribution as 0.67, 245 
0.57 and 0.74 for OXO, FLUQ and ENRO respectively. The MIC COWT values 246 
calculated from these data were ≤0.25 mg L-1 for OXO, ≤0.125 mg L-1 for FLUQ and 247 
≤0.032 mg L-1 for ENRO (Table 5). When these COWT values were applied, 21 (16%), 20 248 
(15%) and 20 (15%) of the 133 isolates were categorised as WT with respect to OXO, 249 
FLUQ and ENRO respectively.  250 
Scatterplots of the MIC data for OXO against those for FLUQ and ENRO (Figure 251 
3B and 3C) demonstrated a high (>97.7%) categorical agreement in both cases. This 252 
suggests that it would be safe to accept MIC data for OXO as a predictor of reduced 253 
susceptibility to the FLUQ and ENRO (Smith et al. 2016). Adoption of this proposal 254 
would reduce the cost of routine susceptibility testing. 255 
The disc diffusion zone sizes for OXO2 were bimodal (Figure 1D). NRI analysis of 256 
these data calculated a standard deviation of the normalised WT distribution of 8.5 mm. 257 
This high standard deviation is probably a result of the fact that high zone modal group 258 
was diverse and composed of only a few observations. This suggests that the disc COWT 259 
value calculated by NRI analysis of ≥30 mm (Table 6) should only be treated as a 260 
provisional value. Applying the cut-off of ≤0.25 mg L-1 to the MIC data for OXO and the 261 
disc zone cut-off of ≥30 mm to the zone data resulted in 99% agreement in the 262 
categorisation of the 133 isolates studied (Figure 2D).  263 
The disc diffusion zone sizes for FLUQ were not determined and those for ENRO 264 
did not show any visually obvious high zone modal group and were not subject to NRI 265 
analysis (Figure 1E). 266 
 267 
Erythromycin 268 
MIC values of ERY had a unimodal distribution. NRI analysis calculated a standard 269 
deviation of the log2 normalised WT distribution of 0.98 and the COWT value was 270 
calculated as ≤8 mg L-1 (Table 3 and 5). This value determined that all 133 F. 271 
psychrophilum isolates analysed were WT for ERY.  272 
 273 
Ormetoprim/Sulphadimethoxine and Trimethoprim/Sulphamethoxazole 274 
The distributions of the MIC values for these two potentiated sulfonamide agents were 275 
diverse but appeared to be unimodal (Table 3). NRI analysis generated provisional COWT 276 
values for PRI and SXT of ≤320 mg L-1 and ≤160 mg L-1, respectively. However, the 277 
standard deviations calculated for the normalized distribution of these putative WT 278 
observations, 1.39 log2 mg L-1 and 1.67 log2 mg L-1 for PRI and SXT respectively, were 279 
higher than those recorded for all other agents in this work (Table 5). Therefore, the 280 
validity of these COWT values was questionable.  281 
The disc diffusion zone sizes for SXT did not show any visually obvious high zone 282 
modal group and were not subject to NRI analysis (Figure 1F). 283 
 284 
Discussion 285 
Data precision 286 
Precision of MIC data sets 287 
The precision of any COWT value is a function of the precision of the observational data 288 
used to calculate it. Smith et al. (2012) demonstrated that the standard deviations of the 289 
normalised distributions of the log2 WT observation calculated by the NRI analysis could 290 
provide a proxy measurement of precision. The median of the standard deviation 291 
calculated for 22 F. psychrophilum data sets published by Michel et al. (2003), Smith et 292 
al. (2016) and Van Vliet et al. (2017) was 0.70 log2 mg L-1. In this work, the median 293 
value of standard deviations calculated for ENRO, ERY, FFN, FLUQ, OTC and OXO 294 
(Table 5) was 0.72 log2 mg L-1. This suggests that the MIC data sets obtained in this work 295 
for these agents were of an acceptable level of precision and were of sufficient quality 296 
that they could be used to calculate COWT values.  297 
The standard deviations calculated for potentiated sulphonamide MIC data, 1.39 298 
log2 mg L-1 and 1.61 log2 mg L-1 for PRI and SXT respectively in this work, were, 299 
however, considerably larger and were taken to indicate significant imprecision. Smith et 300 
al. (2016) and Van Vliet et al. (2017), who used the same testing protocol as was used in 301 
this work also reported very low precision in the MIC data they obtained for these agents 302 
(mean 1.43 log2 mg L-1). Due to their low precision, it was considered that valid COWT 303 
could not be established for PRI and SXT data obtained in this work. 304 
 305 
Precision of disc diffusion data sets 306 
Smith & Kronvall (2015) analysed zone data for reference control strains E. coli ATCC 307 
25922 and Aeromonas salmonicida ATCC 33658 and demonstrated a reduction in 308 
precision as the incubation temperature decreased and time increased. Analysis of the 309 
data obtained from the reference strain F. psychrophilum NCIMB 1947T and from the test 310 
isolates in this work suggest a similar effect of temperature and time on precision of zone 311 
size data.  312 
The mean of the ranges of zone sizes for the control reference strain E. coli NCIMB 313 
12210 provided in the guideline VET03-A (CLSI 2006) for tests performed at 35°C, 314 
28°C and 22°C were 7.7 ± 0.8 mm, 8.0 ± 1.5 mm and 11.8 ± 2.0 mm respectively (Smith 315 
and Kronvall 2015). In this work, the mean range obtained at 15oC for six agents against 316 
the control strain F. psychrophilum NCIMB 1947T was 16.5 mm ± 7.6 mm  317 
The mean of standard deviations of the 19 zone data sets obtained at 28oC in studies 318 
of Edwardsiella tarda and Vibrio harveyi was 2.53 mm (Lim et al. 2016). For 13 data 319 
sets of A. salmonicida obtained at 22oC, the mean was 3.9 mm (Miller & Reimschuessel 320 
2006; Smith et al. 2007). In this work, the disc diffusion assays were performed at 15oC 321 
and the mean standard deviation of the normalised distributions of the four disc data sets 322 
was 6.7 mm. 323 
These comparisons suggest that the low precision of the zone data sets obtained in 324 
this work was most probably a function of the inherent property of this type of assay 325 
rather than any laboratory specific errors in the performance of the assays. However, the 326 
low level of precision suggests that any COWT calculated from these zone data should be 327 
treated as only provisional estimates. 328 
 329 
Categorical agreements 330 
With the calculated MIC COWT and provisional disc diffusion-based COWT of FFN, OXO 331 
and OTC, it is possible to calculate the percentage agreement between the categorisation 332 
of the 133 isolates obtained by analysing the observed MIC measures and the zone size 333 
data. The values of these categorical agreements were 100% for FFN, 99% for OXO and 334 
93% for OTC. This high level of categorical agreement raise the possibility that, although 335 
the disc diffusion protocol used in this work generated data of low precision, the 336 
provisional COWT calculated from them may have some value in detecting isolates of 337 
reduced susceptibility.  338 
It should, however be noted that Smith & Kronvall  (2015) demonstrated that 339 
reduced temperatures and prolonged incubation time increased not only the level of intra-340 
laboratory variation but also the level of inter-laboratory variation in the data generated. 341 
High inter-laboratory variation of the data will have the consequence that although any 342 
provisional disc COWT calculated in one laboratory may have some value in interpreting 343 
zone data produced in that laboratory, it may be misleading if applied to zone data 344 
obtained in another laboratory. In other words, the COWT values for MIC data calculated 345 
in this work are probably laboratory-independent and of general or ‘universal’ 346 
applicability. However, it is probably safer to treat the COWT values for inhibition zone 347 
data generated in this work as only of local applicability. As a consequence, each 348 
laboratory using this protocol to perform disc diffusion assays would have to generate 349 
their own COWT values. The disc diffusion test protocol used in this work has not been 350 
accepted as a standard by CLSI. It is possible that further optimisation such as using a 351 
higher incubation temperature (18oC) may lead to a protocol with increased precision.  352 
 353 
Comparison of COWT values calculated for MIC measures determined by 354 
standardised broth microdilution protocols of CLSI for F. psychrophilum 355 
The values for any COWT are protocol-specific. It is, therefore, legitimate to compare the 356 
COWT calculated in this work with those published by Smith et al. (2016) and Van Vliet 357 
et al. (2017), who also used the standardised broth microdilution protocol (CLSI 2014a) 358 
and NRI method to calculate COWT for F. psychrophilum from MIC data. This 359 
comparison can be made with respect to three agents (FFN, OXO and OTC). For FFN 360 
and OXO, the same COWT values (≤2 mg L-1 and 0.25 mg L-1 respectively) were 361 
calculated from all three studies. For OTC, Smith et al. (2016) and Van Vliet et al. (2017) 362 
calculated a COWT of ≤0.125 mg L-1 compared to the 0.25 mg L-1 calculated in this work. 363 
It should, however, be noted that in this work, no isolates were recorded as manifesting 364 
an MIC of 0.25 mg L-1 for OTC (Table 3) and the categorisation of the 133 isolates 365 
studied here would be the same if either COWT value was applied to them. This 366 
agreement in the COWT values calculated illustrates the value of the use of standardised 367 
test protocols and statistically based interpretive criteria and suggests that it should be 368 
possible for CLSI to set internationally applicable, laboratory-independent ECVs for this 369 
species. 370 
 371 
Frequencies of UK F. psychrophilum isolates with reduced susceptibility 372 
Applying the COWT values calculated or, in the case of AMP, estimated in this work 373 
(Table 5) to the MIC data from these 118 UK F. psychrophilum isolates, the frequencies 374 
of those with reduced susceptibility were 92% for FLUQ, 90% for ENRO, 88% for OXO, 375 
58% for OTC, 32% for AMP and no isolates were recorded with reduced susceptibility 376 
for FFN and ERY. However, as noted by Smith et al. (2016), ERY, a drug whose primary 377 
value is in treating infections by gram-positive bacteria, has never been recommended for 378 
the control of F. psychrophilum infections of aquatic animal. There have been two earlier 379 
studies of NWT frequencies in UK F. psychrophilum isolates. Rangdale et al. (1997) 380 
investigated the susceptibility of 47 F. psychrophilum isolates, 36 of which were 381 
collected in the UK. However, their MIC data sets were of very low precision (mean log2 382 
standard deviation for FFN, OTC and OXO of 3.24 log2 mg L-1) and therefore, reliable 383 
estimates of NWT frequencies could not be assessed. In a smaller study (27 UK F. 384 
psychrophilum isolates) that used the same testing protocol and statistically based 385 
interpretive criteria as used in this work, Smith et al. (2016) reported NWT frequencies 386 
similar to those reported here. When the isolates studied here are combined those studied 387 
by Smith et al. (2016), the frequency of NWT phenotypes in the 145 UK isolates 388 
obtained during 2005 – 2015 were 85%, 59% for OXO and OTC respectively, and no 389 
NWT phenotypes were reported for FFN. 390 
  391 
Antibiotic use in UK rainbow trout farming 392 
Verner-Jeffreys & Taylor (2015) reported the use of four agents (FFN, OXY, AMOX and 393 
OXO) in attempts to control RTFS in the UK. The survey revealed that FFN was the 394 
treatment of choice in the industry. These FFN treatments were generally considered very 395 
effective. Where other antimicrobials (OTC, OXO or AMOX) were used, the therapeutic 396 
response was reported as either mixed or poor. 397 
These anecdotal reports of comparative treatment efficacies reflect closely the 398 
frequencies with which isolates of reduced susceptibility were detected in this work. This 399 
in turn suggests that routine susceptibility testing, associated with appropriate 400 
interpretation of these data obtained, would be cost-effective and an essential element in 401 
the prudent use of antibiotics in aquaculture. 402 
Verner-Jeffreys & Taylor (2015) reported that within the UK most batches of 403 
rainbow trout were treated with FFN at least once during every production cycle. Thus, 404 
given the relatively high frequency of NWT phenotypes detected with respect to the 405 
alternative agents available (OXO, OTC and AMOX), it would appear that, as it currently 406 
operates, the UK rainbow trout industry is critically dependent on the continued clinical 407 
efficacy of FFN. Some concern must be expressed about the long-term sustainability of 408 
an industry that would be affected by the emergence of strains of F. psychrophilum that 409 
were clinically resistant to this agent. 410 
As FFN is the agent of choice to treat F. psychrophilum infection in many countries, 411 
it is reasonable to postulate that this critical dependence of the continued clinical efficacy 412 
of FFN is not unique to the UK but is wide-spread in the global trout farming industry. 413 
The global situation with respect to FFN susceptibility of F. psychrophilum can be 414 
assessed from a number of studies that have been published. Studies that have employed 415 
standard MIC testing protocols and that generated data of adequate precision have been 416 
reported from Denmark and the UK (Smith et al. 2016), Chile (Miranda et al. 2016) and 417 
USA (Van Vliet et al. 2017). Studies of the antimicrobial susceptibility of Danish (Bruun 418 
et al. 2000) and French (Michel et al. 2003) F. psychrophilum isolates that used non-419 
standardised agar dilution protocols have also been published Combining the data 420 
presented in these studies with the data generated in this study provides a total of 829 421 
measurements of FFN susceptibility, of which only two (0.2%), both collected in Chile, 422 
were categorised as NWT with respect to FFN. Recently the presence of a region 423 
containing resistance genes to florfenicol (floR), tetracycline (tetX), streptothricin and 424 
chloramphenicol acetyltransferase gene was detected in Chryseobacterium spp. from 425 
rainbow trout (Verner-Jeffreys et al. 2017). However, this resistance gene cassette was 426 
not widely distributed in Flavobacteriaceae isolates (Verner-Jeffreys et al. 2017). 427 
These data would indicate, rather surprisingly, that the selective pressure that must 428 
have resulted from the use of this agent during the 25 or more years since the introduction 429 
of the antibiotic to aquaculture (Smith 2008) has not yet resulted in any significant 430 
emergence of strains of F. psychrophilum strains with reduced susceptibility to this agent. 431 
However, it cannot be automatically assumed that this situation will continue. Given the 432 
significance of FFN to the global trout farming industry, and as recommended by the 433 
World Animal Health Organisations (http://www.oie.int/international-standard-434 
setting/aquatic-code/access-online), it is essential that programmes designed to detect any 435 
emergence of isolates of F. psychrophilum with reduced susceptibility to this agent are 436 
implemented as a matter of urgency by all relevant authorities.  437 
 438 
Conclusions 439 
Interpretation of MIC data by NRI analysis for F. psychrophilum generated by the 440 
standardised microdilution protocol (CLSI 2014a) provided an overview of the 441 
frequencies of isolates manifesting reduced susceptibility in 118 UK isolates. There was a 442 
general agreement between the frequencies of isolates manifesting WT phenotypes for 443 
the agents FFN, OXO and OTC, observed in this work, and the reports of their clinical 444 
success when used in commercial farms in the UK. On the basis of this, it is strongly 445 
recommended that, in order to ensure rational and prudent use of antibiotics to control F. 446 
psychrophilum infections, susceptibility testing using standardised methods should be 447 
performed in association with all on-farm administrations of the antibiotics.  448 
The Aquatic Animal Health Code of the World Animal Health Organisation 449 
recommends that all relevant authorities should implement programmes for the 450 
monitoring and surveillance of the susceptibility of aquatic animal pathogens to 451 
antibiotics used in their areas. As the UK trout farming industry is critically dependent on 452 
the continued efficacy of FFN in the control of RTFS, the implementation of such a 453 
programme with respect to F. psychrophilum would appear to be a priority for the UK. 454 
The standardised MIC susceptibility testing protocol of CLSI and the epidemiological 455 
cut-off values developed in this work would provide the analytical methods for such a 456 
programme.  457 
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  663 
Table 1. Summary of 118 UK F. psychrophilum isolates analysed in this study 664 
RT, rainbow trout; AS, Atlantic salmon 665 
(*) Genotypes and plasmid profiles of F. psychrophilum isolates determined by Ngo et al. (2017). 666 
 667 
  668 
Location 
Host 
source  
No. 
of 
sites 
Site 
Year of 
isolation 
No. of 
sampling 
times 
No. of 
strains  
No. of 
genotypes
(*) 
No. of 
plasmid 
profiles 
(*) 
Scotland 
RT(93)/ 
AS(14) 
20  
 
2005-2015 46 102 47 7 
   
Scot I  2005-2014 16 25 11 4 
   
Scot II  2013 1 1 1 1 
   
Scot III  2011-2015 4 13 9 4 
   
Scot IV  2013 1 5 2 2 
   
Scot V  2013-2015 4 27 16 5 
   
Scot VI  2009 1 1 1 1 
   
Scot VII  2007 1 1 1 1 
   
Scot VIII  2005 1 1 1 1 
   
Scot IX 2006 1 1 1 1 
   
Scot X 2011-2013 2 3 2 1 
   
Scot XI 2015 1 4 3 1 
   
Scot XII 2010 1 1 1 1 
   
Scot XIII 2005 1 1 1 1 
   
Scot XIV 2013 1 2 1 1 
   
Scot XV 2013 2 3 2 1 
   
Scot XVI 2014-2015 4 9 4 3 
   
Scot XVII 2007 1 1 1 1 
   
Scot XVIII 2009 1 1 1 1 
   
Unknown (2) 2009-2012 2 2 2 2 
England RT 6 
 
2007-2015 8 13 5 2 
   
Eng I 2013 3 8 4 2 
   
Eng II 2015 1 1 1 1 
   
Eng III 2015 1 1 1 1 
   
Eng IV 2015 1 1 1 1 
   
Eng V 2007 1 1 1 1 
   
Eng VI 2007 1 1 1 1 
Northern 
Ireland 
RT 1 N Ire I 2013 2 3 2 2 
Total 
RT(111)/
AS(14)    
2005-2015 56 118 51 7 
Table 2. Fifteen F. psychrophilum isolates from outside the UK used in this study 669 
 670 
RT, rainbow trout; AS, Atlantic salmon; CS, coho salmon 671 
a Pulsotypes and plasmid profiles of F. psychrophilum isolates determined by Ngo et al. (2017). 672 
b including the F. psychrophilum type strain NCIMB 1947T 673 
  674 
 675 
Countries Host source  Year of isolation 
No. of 
strains  
No. of 
genotypesa 
No. of 
plasmid 
profilesa 
Chile RT 1995-1997 2 2 2 
Denmark RT 1990-1994 3 3 1 
Finland RT 1996 2 2 1 
France RT unknown-2013 3 2 1 
Ireland AS 2006 1 1 1 
USAb RT(3)/CS(1) unknown - 2004 4 4 2 
Total  RT(13)/AS(1)/CS(1) unknown - 2013 15 13 3 
Table 3. MIC values (mg L-1) determined for 133 F. psychrophilum isolates  676 
 
Off scale 0.002 0.004 0.008 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 Off scale 
β lactams 
                
AMOX 93               
  
19 13 8 
   
                 
AMP 24         
 
66 3 
  
15 17 8 
   
Macrolides 
                
ERY 4               
 
4 24 93 8 
   
Phenicols 
                
FFN 
 
        
  
1 9 69 54 
     
Quinolones 
                
ENRO 
   
7 10 3 3 51 17 14 28         
 
                 
FLUQ 
 
    
  
3 16 1 1 3 41 13 13     42 
                 
OXO 
 
  
    
7 13 1 1 6 47       58 
Tetracyclines 
               
OTC 
 
      
 
12 40 4 
 
2 
 
7 33 32   3 
 
Off scale 0.002 0.004 0.008 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 Off scale 
Shaded areas indicate MIC values could not be determined using Sensititre CMP1MSP plates. 677 
Off scale indicates the number of strains whose MIC lay outside of the range that could be determined using these plates. 678 
 679 
  680 
Table 4. MIC values (mg L-1) determined for potentiated sulphonamide drugs against 133 F. psychrophilum isolates 681 
 682 
 
Off scale 0.008/0.15 0.015/0.30 0.03/0.59 0.06/1.19 0.12/2.38 0.25/4.75 0.5/9.5 1/19 2/38 4/76 Off scale 
PRI 
     
1 2 15 28 43 29 15 
             
SXT 
 
  
  
1 11 37 30 48     6 
             
 683 
Shaded areas indicate MIC values could not be determined using Sensititre CMP1MSP plates. 684 
Table 5. Cut-off values (COWT) calculated using NRI from 133 MIC observations 685 
Agent 
Number of  
WT observations 
Standard 
deviation a 
(log2 mg L-1) 
COWT (mg L-1) 
AMPb 93 (70%) NDc ≤ 0.125 
ENRO 20 (15%) 0.74 ≤ 0.032 
ERY 133 (100%) 0.98 ≤ 8 
FFN 133 (100%) 0.68 ≤ 2 
FLUQ 20 (15%) 0.57 ≤ 0.125 
OTC 56 (42%) 0.68 ≤ 0.25 
OXO 21 (16%) 0.67 ≤ 0.25 
PRI 133 (100%) 1.39 ≤ 16/304 
SXT 133 (100%) 1.61 ≤ 8/152 
a Standard deviation of the normalised distribution of MIC values for WT strains. 686 
b COWT value of AMP was estimated by visual examination.  687 
c ND: not determined 688 
  689 
 690 
Table 6. Provisional cut-off values (COWT) calculated using NRI from 133 inhibition zone 691 
observations 692 
Agent 
Number of  
WT observations 
Standard 
deviation* 
(mm) 
COWT (mm) 
AMOX10 90 (68%) 5.20 ≥56 
FFN30 133 (100%) 5.61 ≥45 
OTC30 65 (49%) 7.44 ≥51 
OXO2 20 (15%) 8.50 ≥30 
* Standard deviation of the normalised distribution of MIC values for WT strains. 693 
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Figure 1. Distribution of 133 F. psychrophilum strains according to inhibition zone 738 
diameters generated by disc diffusion method for 30 µg oxytetracycline (A, OTC30), 739 
10 µg amoxicillin (B, AMOX10), 30 µg florfenicol (C, FFN30), 2 µg oxolinic acid (D, 740 
OXO2), 5 µg enrofloxacin (E, ENRO5) and 25 µg trimethoprim/sulphamethoxazole (F, 741 
SXT25). The continuous line represents the 8 point rolling means, the vertical dashed 742 
line represents the calculated disc diffusion-based cut-off value. 743 
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Figure 2. Plot of 133 paired MIC values versus disc diffusion zone diameters for 767 
oxytetracycline (A), florfenicol (B) and oxolinic acid (C). A continuous thick line 768 
presents the calculated cut-off line of the microbial agent.  769 
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Figure 3. Plot of 133 paired MIC values between antimicrobial agents within beta-788 
lactam group (A: ampicillin and amoxicillin) and quinolone group (B: oxolinic acid 789 
and flumequine; C: oxolinic acid and enrofloxacin). A continuous thick line presents 790 
the calculated cut-off line of the microbial agent. A dashed line presents an estimated 791 
cut-off value. 792 
